Published in Acta Obstet Gynecol Scand on March 29, 2013
Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis (2014) 0.89
Using the nonhuman primate model of HCMV to guide vaccine development. Viruses (2014) 0.81
Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels. AIDS Res Hum Retroviruses (2016) 0.77
Reply to Itzhaki and Klapper. J Infect Dis (2013) 0.75
Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry (2013) 1.63
LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet (2003) 1.59
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol (2004) 1.51
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol (2006) 1.49
Glycoconjugate glycans as viral receptors. Ann Med (2005) 1.48
The clinical spectrum of lichen sclerosus in male patients - a retrospective study. Acta Derm Venereol (2014) 1.39
Valganciclovir in patients with glioblastoma. N Engl J Med (2013) 1.21
Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol (2009) 1.19
Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol (2007) 1.16
Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors (2012) 1.14
Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J (2005) 1.09
Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol (2006) 1.08
Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol (2005) 1.08
Detection of bacterial DNA in painful degenerated spinal discs in patients without signs of clinical infection. Eur Spine J (2004) 1.07
Human Tick-Borne Encephalitis and Characterization of Virus from Biting Tick. Emerg Infect Dis (2016) 1.07
Enteric viruses in healthy children in Cameroon: viral load and genotyping of norovirus strains. J Med Virol (2011) 1.05
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res (2004) 1.05
Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J Biol Chem (2006) 1.05
Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J Biol Chem (2005) 1.04
A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations. PLoS One (2011) 1.03
Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection. J Gen Virol (2012) 1.02
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One (2011) 1.01
Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol (2002) 1.01
Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology (2004) 0.99
Genetic recombination of tick-borne flaviviruses among wild-type strains. Virology (2013) 0.97
Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates. J Clin Microbiol (2002) 0.95
Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes. J Clin Microbiol (2006) 0.94
Recombination of Globally Circulating Varicella-Zoster Virus. J Virol (2015) 0.94
Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol (2002) 0.93
Molecular analysis of an oyster-related norovirus outbreak. J Clin Virol (2009) 0.92
Comparison of rectal swabs and faeces for real-time PCR detection of enteric agents in Rwandan children with gastroenteritis. BMC Infect Dis (2013) 0.92
Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. Virology (2002) 0.91
Shift of Enterovirus species among children in Cameroon--identification of a new enterovirus, EV-A119. J Clin Virol (2013) 0.90
Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs (2013) 0.90
Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol Pharm Bull (2008) 0.90
Tracing of norovirus outbreak strains in mussels collected near sewage effluents. Appl Environ Microbiol (2008) 0.89
Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ (2004) 0.88
Marked genomic diversity of norovirus genogroup I strains in a waterborne outbreak. Appl Environ Microbiol (2012) 0.88
Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis (2003) 0.87
Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J Gen Virol (2002) 0.87
Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients. AIDS Res Hum Retroviruses (2010) 0.87
A 3'-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans. J Gen Virol (2008) 0.87
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz (2008) 0.86
The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res (2008) 0.86
Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy. Scand J Infect Dis (2014) 0.86
Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity. Glycobiology (2004) 0.86
CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J Gen Virol (2004) 0.86
Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology. J Virol Methods (2011) 0.86
Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol (2005) 0.85
Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome. J Inflamm (Lond) (2010) 0.85
Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease. J Virol (2012) 0.85
Real-time PCR identification of agents causing diarrhea in Rwandan children less than 5 years of age. Pediatr Infect Dis J (2014) 0.85
Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol (2007) 0.84
Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells. J Virol (2007) 0.84
Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis. Clin Vaccine Immunol (2011) 0.84
Asymptomatically shed recombinant herpes simplex virus type 1 strains detected in saliva. J Gen Virol (2009) 0.84
Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J Neuroimmunol (2009) 0.84
Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1. Clin Vaccine Immunol (2011) 0.83
Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden. Acta Derm Venereol (2009) 0.83
The calcitonin receptor gene is a candidate for regulation of susceptibility to herpes simplex type 1 neuronal infection leading to encephalitis in rat. PLoS Pathog (2012) 0.82
Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Res (2010) 0.82
Oxygen radical production and severity of the Guillain--Barré syndrome. J Neuroimmunol (2007) 0.82
Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis. PLoS One (2010) 0.82
Identification of RIP-II toxins by affinity enrichment, enzymatic digestion and LC-MS. Anal Chem (2014) 0.81
Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Res (2004) 0.81
2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2012) 0.81
Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm Venereol (2006) 0.80
Early acquisition of herpes simplex virus type 1 antibodies in children--a longitudinal serological study. J Clin Virol (2007) 0.80
Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis. J Neurovirol (2008) 0.80
Solvent-assisted trypsin digestion of ricin for forensic identification by LC-ESI MS/MS. Anal Chem (2007) 0.80
Glycoprotein I of herpes simplex virus type 1 contains a unique polymorphic tandem-repeated mucin region. J Gen Virol (2007) 0.80
The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection. J Neurovirol (2015) 0.80
Retinal degeneration in nine Swedish Jämthund dogs. Vet Ophthalmol (2010) 0.80
Type-specific reactivity of anti-glycoprotein G antibodies from herpes simplex virus-infected individuals is maintained by single or dual type-specific residues. J Gen Virol (2005) 0.80
Detection of hepatitis A virus genotype IB variants in clams from Maputo Bay, Mozambique. J Med Virol (2006) 0.80
A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-1 reacts sensitively and specifically with HSV-1 antibodies in an ELISA. J Virol Methods (2005) 0.79
Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis. J Virol (2012) 0.79
Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays. Glycoconj J (2013) 0.78
[Increasing number of Chlamydia infections--how can we reverse this trend?]. Lakartidningen (2002) 0.78
Anti-herpes simplex virus activities of two novel disulphated cyclitols. Antivir Chem Chemother (2006) 0.78
[Secondary syphilis with ocular involvement in a 77-year-old man]. Lakartidningen (2005) 0.77
STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection. J Virol (2012) 0.77
Molecular analysis of enterovirus in Cameroon by partial 5'UTR-VP4 gene sequencing reveals a high genetic diversity and frequency of infections. J Med Virol (2014) 0.77
Clinical and microscopic signs of cervicitis and urethritis: correlation with Chlamydia trachomatis infection in female STI patients. Acta Derm Venereol (2013) 0.77
Leukocyte myeloperoxidase and pathogenesis of the post-polio syndrome. Scand J Infect Dis (2010) 0.77
Microglial GLT-1 is upregulated in response to herpes simplex virus infection to provide an antiviral defence via glutathione. Glia (2007) 0.76
Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate. Antiviral Res (2011) 0.76
The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms. Ann N Y Acad Sci (2011) 0.76
Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1. Antiviral Res (2010) 0.76
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome. J Neuroimmunol (2012) 0.76